RxDoctor Payments Data

Jonathan Ramirez Vazquez, MD

Surgery · Manati, PRNPI 1154736940

Payments from drug & device makers

$1,176in general payments, 2019–2025

Across 17 payments — averaging $69.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$362
  • Johnson And Johnson International$225
  • Johnson & Johnson$177
  • Edwards Lifesciences$169
  • Bard Access Systems, Inc.$139
  • BD$82
  • plus $22 from 2 others

What the payments were for

  • Food & beverage$1,176100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)2$362
Johnson And Johnson International3$225
Johnson & Johnson4$177
Edwards Lifesciences3$169
Bard Access Systems, Inc.1$139
BD2$82
Chiesi USA, Inc.1$19
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,176 in reported general payments places this provider in the 60th percentile of 202 surgery providers in Puerto Rico.

See all surgery providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$6,807
Medicare patients
17
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine14$427

Paid to pharmacies, not to this prescriber.

Other surgery in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →